Boule Diagnostics AB (publ)

BST:8BD Stock Report

Market Cap: €29.8m

Boule Diagnostics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Torben Nielsen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.8yrs

Recent management updates

Recent updates


CEO

Torben Nielsen

no data

Tenure

Mr. Torben Nielsen is Chief Executive Officer and Group President of Boule Diagnostics AB (publ). Mr. Nielsen joined the Boule Diagnostics AB (publ) in April 2024.


Leadership Team

NamePositionTenureCompensationOwnership
Torben Nielsen
CEO & Group Presidentno datano datano data
Holger Lembrer
Chief Financial Officerless than a yearno datano data
Eduardo Pagani
Chief Operating Officerno datano datano data
Simonetta Tumbiolo
Senior Vice President of Marketingless than a yearno datano data
Aishat Bislieva
Senior Vice President of People & Culture2.3yrsno datano data

1.0yrs

Average Tenure

Experienced Management: 8BD's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Yvonne Martensson
Independent Director3.7yrsSEK 500.00k0.038%
€ 11.4k
Thomas Eklund
Director11yrsSEK 300.00k10.4%
€ 3.1m
Karin Dahllof
Independent Director10yrsSEK 250.00k0.057%
€ 17.1k
Rikke Rytter
Directorless than a yearno datano data
Emil Hjalmarsson
Director3yrsSEK 125.00k0.067%
€ 19.9k
Torben Jorgensen
Independent Chairman of the Board4yrsSEK 250.00k0.051%
€ 15.3k

3.8yrs

Average Tenure

61yo

Average Age

Experienced Board: 8BD's board of directors are considered experienced (3.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 06:45
End of Day Share Price 2025/01/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boule Diagnostics AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jakob LembkeABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored
Christian LeePareto Securities